Status:

UNKNOWN

Study to Assess the Efficacy of the iTind in Subjects With Symptomatic BPH

Lead Sponsor:

Medi-Tate Ltd.

Conditions:

BPH

Eligibility:

MALE

18+ years

Phase:

NA

Brief Summary

A total of up to 200 Symptomatic BPH subjects subjects will be enrolled into the study. Study duration will be 12 months post implantation with a follow-up visits at Year 2 and Year 3.

Detailed Description

Primary Study Objective: The study's primary objective is to assess the efficacy of the Medi-Tate iTind in subjects with symptomatic BPH by reduction of IPSS) (International Prostate Symptoms Score) ...

Eligibility Criteria

Inclusion

  • Subject signed informed consent prior to the performance of any study procedures.
  • Male with symptomatic BPH: IPSS symptom severity score ≥ 10
  • Peak urinary flow of \< 12 ml/sec at flowmetry with minimum voided volume of at least 120 cc.
  • Prostate volume 25 ml to 80 ml (as assessed by TRUS)
  • Subject that is able to complete the study protocol
  • Normal Urinalysis and urine culture.

Exclusion

  • Previous prostate surgery
  • Prostate cancer
  • Urethral stricture
  • Bladder stones
  • An active urinary tract infection.
  • Obstructing median lobe demonstrated by IPP grade 3 (\>1 cm) as assessed by TRUS.
  • Neurological conditions potentially affecting voiding function.
  • A post void residual (PVR) volume \> 250 ml measured by ultrasound
  • Previous diagnosis or treatment for Over Active Bladder
  • Acute Urinary Retention
  • Any anatomical or physiological condition that in the opinion of the investigator likely to impede successful completion of the study
  • Intra-Operation Exclusion:
  • • Obstructing median lobe or any other anatomical or physiological pathology that can interfere the device implantation as assessed by cystoscopy.

Key Trial Info

Start Date :

February 18 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 25 2025

Estimated Enrollment :

149 Patients enrolled

Trial Details

Trial ID

NCT03395522

Start Date

February 18 2018

End Date

April 25 2025

Last Update

October 23 2023

Active Locations (12)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (12 locations)

1

Sydney Adventist Hospital Clinical School of the University of Sydney

Sydney, Australia

2

Hospital Center University De Bordeaux

Bordeaux, France

3

Hôpital Cochin

Paris, France

4

Hôpital Privé des Côtes d'Armor

Plérin, France